EU0200080001

Nom de l'organisation

BGI EUROPE A/S

SRN

DK-MF-000014089

Statut du fabricant

Actif

2 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW010

  Caution, risk of crushing hands. When opening or closing the solvent manager, sample manager, and column oven doors, operate carefully to avoid crushing hands.
• CW008

  Be cautious of biohazards. When using biohazardous samples and reagents, be sure to wear gloves, lab gowns to prevent infection, and safety glasses if necessary. Be sure to follow local regulations for hazard assessment, control and handling.

Marché principal en Danemark ; disponible dans 1 pays au total.

Commercialisé en Danemark ; dates par pays non publiées.

Dénomination commerciale

non renseigné

Code d'UDI-DI

05744003510146

Basic UDI-DI

574400351EU0200080001RZ

Numéro de référence/catalogue

EU0200080001

Entité d'attribution

GS1

Catégorie de risque

IVDR Classe A

Législation applicable

IVDR [Règlement (UE) 2017/746 relatif aux dispositifs médicaux de diagnostic in vitro]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

The BGI LMSQ-1000 liquid chromatography tandem mass spectrometer is designed based on a combination of both chromatography and mass spectrometry technique, which is intended to be used for the qualitative and quantitative determination of the human derived biological specimens, including analytes such as whole blood, plasma, serum, urine , saliva , hair, etc. for the detecting endogenous and exogenous compounds. Based on chromatography and mass spectrum technology, the analysis of target compounds by Ultra-high performance liquid chromatography (UPLC) after a preliminary separation at atmospheric pressure under the action of ion source or electrospray ion source into charged ions, under the action of charged ions in the air and electric field through the sample cone and the transmission rod, through radio frequency voltage control transmission rod, enter the Q1 quadrupole. The Q1 quadrupole screens the target ions, and the screened ions enter the collision reaction pool and react with the reaction gas to convert into fragments. The fragments enter Q2 quadrupole and are screened in Q2 quadrupole. The screened daughter ions enter the detector to generate the final detection signal.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• W0201050299HIGH PERFORMANCE LIQUID CHROMATOGRAPHY SYSTEMS - OTHER